Select your location.
*e-commerce not available for this region.
The IVISbrite™ LNCaP Red F-luc tumor cell line (Bioware® Brite LNCaP-Red-FLuc) is a light-producing cell line derived from LNCaP human prostate carcinoma. The cells have been stably transduced with the red-shifted firefly luciferase gene from Luciola Italica (Red F-luc), for a brighter, red-shifted signal.
IVISbrite LNCaP Red F-luc Bioluminescent Tumor Cell line
By emitting intensified, longer wavelength light that is significantly brighter than other firefly luciferases, our bioluminescent oncology cell lines allow you to visualize and monitor the growth of deep tissue tumors in vivo.
After the cells are injected into an appropriate mouse model, the optimized Red F-luc luciferase enables more sensitive in vivo optical detection with less tissue attenuation so you can detect tumor development earlier, and monitor tumor growth and metastases in both subcutaneous and orthotopic models.
|Quantity in a Package Amount